• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

MSD

insomnia
Posted inNeuroscience, New Drugs, Regulatory

Quviviq: New Sleeping Pill

January 10, 2022November 5, 2022

Daridorexant will help treat insomnia.

cytomegalovirus
Posted inInfections, New Drugs, Regulatory

Livtencity: New Drug Against Post-Transplant Cytomegalovirus Infection

December 4, 2021September 8, 2022

Maribavir will suppress cytomegalovirus when ganciclovir, valganciclovir, cidofovir, or foscarnet do not work.

Molnupiravir: What U.S. Experts Said
Posted inCOVID-19, Infections, Regulatory

Molnupiravir: What U.S. Experts Said

December 1, 2021September 8, 2022

FDA scientists took a detailed look at molnupiravir for treating COVID-19.

Pneumonia
Posted inInfections, New Drugs, Regulatory

Prevnar 20: New Pneumococcal Vaccine

November 13, 2021September 8, 2022

Pfizer has released an updated and improved version of Prevnar 13, a popular pneumococcal vaccine.

molnupiravir
Posted inCOVID-19, Infections, New Drugs, Regulatory

Lagevrio: New Antiviral Drug to Treat COVID-19

November 4, 2021September 8, 2022

The oral antiviral drug molnupiravir by Merck & Co.

Gastric cancer.
Posted inOncology, Regulatory

Opdivo and Keytruda: First-line Immunotherapy for Gastric Cancer and Esophageal Cancer

April 20, 2021September 8, 2022

Nivolumab or pembrolizumab should be added to standard chemotherapy to prolong the life of patients with gastric, esophageal, and gastroesophageal junction cancers.

Koselugo: First Drug to Treat Neurofibromatosis
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory

Koselugo: First Drug to Treat Neurofibromatosis

April 14, 2021September 8, 2022

Selumetinib by AstraZeneca powerfully suppresses tumor growth in neurofibromatosis type 1.

Posts navigation

Newer posts 1 2 3 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News